meta_pixel
Tapesearch Logo
Log in
WSJ Tech News Briefing

TNB Tech Minute: President Biden Takes to TikTok

WSJ Tech News Briefing

The Wall Street Journal

Tech News, News

4.31.7K Ratings

🗓️ 12 February 2024

⏱️ 2 minutes

🧾️ Download transcript

Summary

Plus: Digital freight startup CDL 1000 acquires competitor NEXT Trucking. And Gilead Sciences expands its portfolio to treat liver disease by acquiring biopharma company CymaBay Therapeutics. Alex Ossola hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Slack presents hands-free conversations.

0:03.2

Hello, car commuter, dog walker, stroller pusher.

0:06.5

Your hands are busy.

0:07.9

It's why we created huddles in Slack, because sometimes talking is easier than typing.

0:12.6

Huddle without the hassle.

0:14.4

In Slack.

0:16.7

Here's your TMB Tech Minute for Monday, February 12th.

0:20.4

I'm Alex Oscela for the Wall Street Journal.

0:23.0

President Biden's campaign has joined Tik-Tok.

0:26.0

A 26-Second video posted to the account last night during the Super Bowl

0:30.0

showed Biden answering questions about which team he was rooting for,

0:33.4

his favorite Kelsey brother, and if he preferred the game or the halftime show.

0:37.5

It's an effort to reach younger voters, just days after a special council report drew fresh

0:42.2

scrutiny about his age and despite national

0:45.0

security concerns over the app.

0:47.5

We are exclusively reporting that Digital Freight Start-Up CDL1,000 has acquired competitor Next Trucking in an equity deal.

0:55.1

The agreement combines Chicago-based CDL1,000's business, which manages loads on short-haul

1:00.2

routes between seaports and warehouses, with similar services at Long Beach, California-based

1:05.2

next trucking focused on the nation's busiest container port complex at Los Angeles and

1:09.7

Long Beach in Southern California.

1:11.8

CDL1,000 didn't reveal terms of the deal.

1:15.0

And Clinical Stage Biopharmaceutical Company, SEMA Bay Therapeutics, has agreed to be acquired

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.